We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Vaccine Design and Testing – News and Features

News

Vical Receives Milestone Payment from Merck Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial

Vical announces receipt of a $1.0 million milestone based on Merck's planned initiation of a Phase I clinical trial of pDNA cancer vaccine.
News

Researchers Discover Strategy for Predicting the Immunity of Vaccines

Emory study reveals how a highly successful vaccine triggers robust immune responses.
News

Alnylam and Collaborators Publish Research on a new Class of Chemically Modified RNAi Therapeutics

New findings published in nature medicine describe “3p-siRNAs,” RNAi therapeutics that both silence specific genes and enhance desired immunostimulatory effects.
News

Canopus BioPharma Announces Positive Results in Human Study of Peptide Cancer Vaccine

Study analyzed at Southern Research Institute shows human antibodies generated by Canopus’s peptides have anti-cancer properties.
News

Neovacs Begins a Phase I/II Clinical Trial for the Treatment of Crohn’s Disease

Neovacs commences the study at three study centres in South Africa with the candidate TNFa-kinoid.
News

VGX Awarded $23.5 Million NIH Contract to Develop Preventive HIV Vaccine Delivered Via Electroporation

U.S. Government grant supports preclinical and clinical development, manufacturing and other activities for VGX’s HIV DNA vaccine candidate.
News

Neovacs and BMD Announce OSEO Innovation Grant for Theranostics Project in Rheumatoid Arthritis

The companies have received a €7.9 million grant to support Tracker, a theranostics project concerning rheumatoid arthritis.
News

MabVax Therapeutics Closes Two Licensing Agreements with Sloan-Kettering Institute for Cancer Research

MabVax gains exclusive development and commercialization rights to multiple vaccines and to use the licensed vaccines and lymphocytes from vaccinated trial participants.
News

GENEART Receives a Grant for the Targeted Design of Vaccine Candidates

GENEART participates in a joint project to develop a novel vaccine technology by designing a vaccine against the H5N1 avian influenza virus as a test case.
News

Inovio Biomedical and VGX Pharmaceuticals Sign Merger Agreement

The agreement provides for the issuance of Inovio Biomedical securities in exchange for all of the outstanding securities of VGX Pharmaceuticals.
Advertisement